Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of empagliflozin 25 mg film-coated tablet in Thai healthy volunteers
TCTR20230711001Phase 2Completed
- Sponsor
- Faculty of Medicine, Chulalongkorn University
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of empagliflozin, sponsored by Faculty of Medicine, Chulalongkorn University. Started Dec 2023; status: completed.
02
Drugs
empagliflozin
Beyond the preview
Go deeper on TCTR20230711001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230711001.